SFE/SFHTA/AFCE consensus on primary aldosteronism, part 7: Medical treatment of primary aldosteronism [0.03%]
原发性醛固酮增多症的诊断与评估中国专家共识（2019更新版）
Antoinette Pechère-Bertschi,Daniel Herpin,Hervé Lefebvre
Antoinette Pechère-Bertschi
Spironolactone, which is a potent mineralocorticoid receptor antagonist, represents the first line medical treatment of primary aldosteronism (PA). As spironolactone is also an antagonist of the androgen and progesterone receptor, it may pr...
Practice Guideline
Annales d'endocrinologie. 2016 Jul;77(3):226-34. DOI:10.1016/j.ando.2016.01.010 2016
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism [0.03%]
原发性醛固酮增多症的基因诊断——共识（五）
Maria-Christina Zennaro,Xavier Jeunemaitre
Maria-Christina Zennaro
While the majority of cases of primary aldosteronism (PA) are sporadic, four forms of autosomal-dominant inheritance have been described: familial hyperaldosteronism (FH) types I to IV. FH-I, also called glucocorticoid-remediable aldosteron...
Practice Guideline
Annales d'endocrinologie. 2016 Jul;77(3):214-9. DOI:10.1016/j.ando.2016.02.006 2016
Laurence Amar,Jean Philippe Baguet,Stéphane Bardet et al.
Laurence Amar et al.
The French Endocrinology Society (SFE) French Hypertension Society (SFHTA) and Francophone Endocrine Surgery Association (AFCE) have drawn up recommendations for the management of primary aldosteronism (PA), based on an analysis of the lite...
Practice Guideline
Annales d'endocrinologie. 2016 Jul;77(3):179-86. DOI:10.1016/j.ando.2016.05.001 2016
SFE/SFHTA/AFCE consensus on primary aldosteronism, part 6: Adrenal surgery [0.03%]
原发性醛固酮增多症的腺瘤手术（第六部分）——《内分泌学会/山地高血压及内分泌学会/临床内分泌外科医师协会关于原发性醛固酮增多症的共识》
Olivier Steichen,Laurence Amar,Philippe Chaffanjon et al.
Olivier Steichen et al.
Treatment of primary aldosteronism (PA) aims at preventing or correcting hypertension, hypokalemia and target organ damage. Patients with lateralized PA and candidates for surgery may be managed by laparoscopic adrenalectomy. Partial adrena...
Practice Guideline
Annales d'endocrinologie. 2016 Jul;77(3):220-5. DOI:10.1016/j.ando.2016.01.009 2016
Sophie Christin-Maitre
Sophie Christin-Maitre
Human chorionic gonadotropin: Different glycoforms and biological activity depending on its source of production [0.03%]
人绒毛膜促性腺激素：其生物活性因来源不同而表现各异的糖基形式
Thierry Fournier
Thierry Fournier
Human chorionic gonadotropin (hCG) is the first hormonal message from the placenta to the mother. It is detectable in maternal blood two days after implantation and behaves like a super LH agonist stimulating progesterone secretion by the c...
SFE/SFHTA/AFCE Consensus on Primary Aldosteronism, part 2: First diagnostic steps [0.03%]
原发性醛固酮增多症初步诊断步骤专家共识（第二部分）
Claire Douillard,Pascal Houillier,Juerg Nussberger et al.
Claire Douillard et al.
In patients with suspected primary aldosteronism (PA), the first diagnostic step, screening, must have high sensitivity and negative predictive value. The aldosterone-to-renin ratio (ARR) is used because it has higher sensitivity and lower ...
Practice Guideline
Annales d'endocrinologie. 2016 Jul;77(3):192-201. DOI:10.1016/j.ando.2016.02.003 2016
Catherine Cardot-Bauters
Catherine Cardot-Bauters
Olivier Sandra
Olivier Sandra
In mammals, implantation represents a key step of pregnancy and its progression conditions not only the success of pregnancy but health of the offspring. Implantation requires a complex and specific uterine tissue, the endometrium, whose bi...
Prokineticin1 and pregnancy [0.03%]
促动力素1和妊娠
Nadia Alfaidy
Nadia Alfaidy
Prokineticin 1 (PROK1), also called EG-VEGF, is a peptide of 86 amino acids with multiple biological functions. PROK1 acts via two G-protein coupled receptors: PROKR1 PROKR2. PROK1 is highly expressed in the placenta. This article reports t...